Replies to post #38429 on Relief Therapeutics Holding AG (RLFTF)

[tcm55]

They have an extension until May...GLTA...

"to extend the date by which Big Rock has to consummate its initial business combination from April 23, 2021 to May 24, 2021"

https://ih.advfn.com/stock-market/NASDAQ/big-rock-partners-acquis-BRPA/stock-news/84779834/additional-proxy-soliciting-materials-definitive-d


NRXP;

NeuroRx established a commercial development partnership with Relief Therapeutics Holding AG (SWX:RLF, OTCQB:RLFTF) ("Relief") in March 2020 for global commercialization of aviptadil which has been the subject of previous press releases.


More time for NRXP.
The 'Jewel' is still RLF-100. Dispite the retorect from NRX the partnership is Relief 80-20% throughout the WORLD and 50-50% US/I/Ca for commercialization of RLF-100.
New Swiss and Turkey Inhaler Trials for Aviptadil by RLF are super significant, IMO.

NRX better get MOVING FAST or their deal passes away.

[PennyWorld]

I wonder if EUA submittal was being held up until this merger agreement was official. Contingencies on EUA is referenced to more than a dozen times in the merger agreement.

[tryn2]

Why does this matter to RLFTF???